Graft Sculpting Brings New Approach to Stem Cell Therapy for Highest Risk AML Patients 

A novel hematopoietic stem cell transplantation (HSCT) method utilizing ‘graft sculpting’ is being tested in a phase 1 clinical trial in patients with refractory acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) who are at the highest risk of relapse after ‘standard’ transplants. In fact, the patients in the trial don’t qualify for a standard … Read more

Dana-Farber Researchers Use Machine Learning to Understand Rare Familial Blood Cancer

Waldenström’s macroglobulinemia (WM) is a blood cancer that is extremely rare, affecting around 1500 people in the US each year. About 20 percent of those cases are considered familial, meaning that many members of the same family also have some form of blood cancer, such as myeloma or lymphoma.  An even smaller group — five … Read more

Breast Cancer Patient Achieves Her Dreams Thanks to Dana-Farber Care 

When Jennifer Fullerton was diagnosed with breast cancer at age 29, her mind immediately went to the worst-case scenario. “I thought I was going to die. That first day all I could think was ‘why me,’” Fullerton says. “My mom very poignantly told me, ‘Today you can say ‘why me,’ but tomorrow, ‘why not me’. And you … Read more

CNS Lymphoma Patient Grateful For Healthy New Chapter of Family Life

Brian Humberd firmly believes in an attitude of gratitude. The biotech recruiter from Melrose, Massachusetts remains eternally grateful to Dana-Farber medical oncologist David Fisher, MD, who not only recommended a life-saving stem cell transplant to treat his central nervous system (CNS) lymphoma, but whose advice enabled Humberd to become a father after his cancer treatments. … Read more

Early Stem Cell Transplant Recipient Says Success Was ‘In the Bag’

By Howard Brown As the Adult Stem Cell Transplant Program at Dana-Farber celebrates its 50th anniversary, one cancer survivor whose 1990 transplant came when the procedure was far more arduous — and far less successful — reflects on his experience. I have a four-by-three-inch plastic bag that I’ve saved for more than 32 years. It’s … Read more

COVID-19 Booster Shots for Most Cancer Patients: What to Know

If you have been vaccinated against COVID-19, the U.S. Centers for Disease Control and Prevention (CDC) recommends different numbers of vaccines depending on if you are immunocompromised. Immunocompromised people can include people who have: As of December 2022, the COVID-19 vaccination recommendation for immunocompromised people, including active cancer patients, includes: A booster dose is another dose given … Read more

Non-Hodgkin Lymphoma and Hodgkin Lymphoma: What’s the Difference?

Hodgkin and non-Hodgkin lymphoma are the two main types of lymphoma, a cancer that affects the lymphatic system. The lymphatic system produces and transports white blood cells to fight infection. While they have many characteristics in common, there are some significant differences between Hodgkin and non-Hodgkin lymphoma, including the age groups they affect, how they … Read more